Similar Articles
Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
Miraç Yıldırım, Ömür Babayiğit, Fatma Ilgaz, Dilek Yalnızoğlu, Meral Topçu
DOI: 10.4274/tnd.2021.12979
Non-pharmacologic Approaches to Dysphagia in Patients with Multiple Sclerosis: A Systematic Review
Gülşah Kesik, Leyla Özdemir
DOI: 10.4274/tnd.2020.55770
The Predictive Value of the Systemic Immune-inflammation Index as a New Prognostic Marker for Disability in Patients with Multiple Sclerosis
Hikmet Saçmacı, Tülin Aktürk, Nermin Tanık
DOI: 10.4274/tnd.2021.50329
The Diagnostic and Prognostic Value of Magnetic Resonance Imaging for Evaluating Atypical Inflammatory Demyelinating Lesions
Zeynep Özdemir, Erkan Acar, Aysun Soysal
DOI: 10.4274/tnd.2021.00907
Decreased Stroke Applications During Pandemic: Collateral Effects of COVID-19
Erman Altunışık, Ali Arık
DOI: 10.4274/tnd.2021.50133
Investigation of the Effects of Game Supported Rehabilitation Program on Motor and Cognitive Skills in a Patient with Co-occurrence of Multiple Sclerosis and Parkinson’s Disease: A Case Report
Gülşah Sütçü, Muhammed Kılınç
DOI: 10.4274/tnd.2020.84594
Epilepsia Partialis Continua in a Patient with Progressive Multiple Sclerosis
Gökhan Görken, Abdullah Yılgör
DOI: 10.4274/tnd.2020.96992
Effects of Body Temperature Lowering on Visual Evoked Potentials in Patients with Multiple Sclerosis
Turan Poyraz, Fethi İdiman, Ahmet Onur Keskin, Leyla İyilikçi Karaoğlan, Egemen İdiman
DOI: 10.4274/tnd.2020.25589
Epidemiology of Multiple Sclerosis in Turkey; A Ten-Year Trend in Rural Cities
Cem Bölük, Ülkü Türk Börü, Mustafa Taşdemir, Tuğçe Gezer
DOI: 10.4274/tnd.2020.36418
Anti-glutamic Acid Decarboxylase Antibody-associated Cerebellar Ataxia: A Case Report
Miray Atacan Yaşgüçlükal, Cansu Tunç, Muhammet Duran Bayar, Birgül Baştan, Sefer Günaydın, Belgin Petek Balcı, Özlem Çokar
DOI: 10.4274/tnd.2020.93457
Family History of Headache and Epistaxis Associated with Ischemic Stroke
Eu Jene Choi, Dong Goo Lee, Do-Hyung Kim, Sang Hyun Jang
DOI: 10.4274/tnd.2020.48902
Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
Beuy Joob, Viroj Wowanitkit
DOI: 10.4274/tnd.2020.99897
Balance and Gait Impairment in Persons with Multiple Sclerosis with the Absence of Clinical Disability
Hatice Ayan, Özge Ertekin, Turhan Kahraman, Serkan Özakbaş
DOI: 10.4274/tnd.2020.36036
A Multifaceted Evaluation of National Off-label Neurology Applications
Şükran Yurtoğulları, Hanife Rahmanlar, Ali Alkan, Banu Bayar, Hakkı Gürsöz, Nurten Uzun Adatepe
DOI: 10.4274/tnd.2020.37791
Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi
DOI: 10.4274/tnd.2020.45467
Awareness of Stroke in the Population Presenting to Outpatient Clinics at a Tertiary Health Institution
Buket Tuğan Yıldız, Mustafa Gökçe, Hamza Şahin
DOI: 10.4274/tnd.2020.47887
The Role of Neurologist in the Assessment and Treatment of Depression
Emre Kumral, Fatma Ece Bayam
DOI: 10.4274/tnd.2019.44341
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Damla Çetinkaya, Seher Naz Yeni
DOI: 10.4274/tnd.2019.22755
Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak
DOI: 10.4274/tnd.2019.34392
Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy
DOI: 10.4274/tnd.2019.77010